What Did EPCAT III Find? – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”What did EPCAT III find?
In more than 5300 patients undergoing total hip or knee arthroplasty, symptomatic proximal DVT or pulmonary embolism occurred in:
- 0.48 percent of patients receiving aspirin alone
- 0.45 of patients receiving rivaroxaban for 5 days followed by aspirin
Aspirin alone met the trial’s prespecified criterion for noninferiority.
The findings provide important new evidence supporting aspirin alone as a thromboprophylaxis option after hip or knee arthroplasty in appropriately selected patients.
Patient selection remains important. Most participants in EPCAT III were classified as standard VTE risk, and patients with previous VTE or metastatic cancer were excluded.
In the latest CLOT Conversations, lead author Dr. Sudeep Shivakumar discusses the results with Dr.Jameel Abdulrehman and what they may mean for clinical practice.
More posts about Thrombosis CanadaThrombosis Canada on Hemostasis Today.
-
Aug 23, 2026, 15:37Nabil Tabish: TEG Reveals the True Effect of Heparin During ECMO
-
Aug 23, 2026, 15:34Ahmed Alotaibi: Could Spray-Dried Plasma Redefine Transfusion Medicine?
-
Aug 23, 2026, 15:23Katerina Pavenski: What’s New in the 2025 AABB and ICTMG Guidelines?
-
Aug 23, 2026, 15:14Denis Nikolov: A Call for Routine UACR Assessment in High-Risk Cardiovascular Patients
-
Aug 23, 2026, 15:1310 Posts Not to Miss This Week
-
Aug 23, 2026, 14:52Alejandro González Veliz: How Plaque Morphology Shapes PCI Outcomes
-
Aug 23, 2026, 14:16Vikram Sinai Talaulikar: Age-Dependent Long-Term Outcomes of Postmenopausal Hormone Replacement Therapy
-
Aug 23, 2026, 14:10Intravenous Arginine Fails to Reduce Acute Sickle Cell Pain – JAMA
-
Aug 23, 2026, 14:00Mohd Ashhad: What Should Be Done Immediately When a Blood Transfusion Reaction Occurs?